Dr. Tarannum Mujtaba, MD, FACR.
Diagnostic and Neuroradiology Specialist
Dual Fellowship in Breast Imaging Radiology and Neuroradiology
Abstract
Breast imaging radiology has experienced significant advancements in recent years, driven by innovations in imaging technology, artificial intelligence (AI), and enhanced imaging protocols. These developments have not only improved the accuracy of breast cancer detection but also provided personalized diagnostic and treatment strategies, minimizing unnecessary biopsies and improving patient outcomes. This review explores the latest advancements in breast imaging, focusing on digital breast tomosynthesis (DBT), contrast-enhanced mammography (CEM), molecular breast imaging (MBI), and the integration of AI in breast imaging diagnostics.
Introduction
Breast cancer remains a leading cause of morbidity and mortality among women worldwide. Early detection is critical for improving survival rates, and radiology plays a pivotal role in the early identification and management of breast cancer. Over the past decade, there has been a significant shift towards more sophisticated imaging techniques that offer better resolution, reduced radiation exposure, and improved diagnostic accuracy. This article reviews the most recent advancements in breast imaging radiology and their implications for clinical practice.
Digital Breast Tomosynthesis (DBT)
Digital Breast Tomosynthesis, often referred to as 3D mammography, has revolutionized breast imaging by providing three-dimensional reconstructions of the breast tissue. Unlike traditional 2D mammography, DBT reduces the issue of tissue overlap, a common cause of false positives and negatives. Recent studies have demonstrated that DBT increases cancer detection rates, particularly for invasive cancers, and reduces recall rates for additional imaging.
One of the significant advancements in DBT is the development of synthesized 2D images from DBT data, which allows radiologists to review both 3D and 2D images without additional radiation exposure. This technique enhances the diagnostic accuracy while maintaining patient safety .
Contrast-Enhanced Mammography (CEM)
Contrast-Enhanced Mammography (CEM) combines traditional mammography with the administration of an iodine-based contrast agent, providing functional imaging in addition to anatomical detail. CEM has shown promising results in detecting lesions that may not be visible on standard mammograms or DBT, particularly in patients with dense breast tissue.
Recent advancements in CEM include the development of dual-energy CEM, further enhancing the contrast between normal and abnormal tissues and making it easier to identify small lesions. Studies have shown that CEM can be a cost-effective alternative to magnetic resonance imaging (MRI) for certain patients, offering similar sensitivity and specificity.
Molecular Breast Imaging (MBI)
Molecular Breast Imaging (MBI) is a nuclear medicine technique that uses a radiotracer to detect metabolic activity in breast tissue. MBI has emerged as a valuable tool for detecting breast cancer, especially in women with dense breasts where traditional mammography may be less effective. The latest advancements in MBI include the use of dual-head gamma cameras and the development of lower-dose radiotracers, which reduce radiation exposure without compromising image quality.
MBI has been particularly useful in detecting small tumors and differentiating between benign and malignant lesions. Its ability to provide functional information about the breast tissue complements the anatomical details obtained from other imaging modalities, offering a more comprehensive assessment of breast abnormalities.
Artificial Intelligence in Breast Imaging
Artificial Intelligence (AI) has made significant inroads into breast imaging, offering tools that can enhance diagnostic accuracy, reduce interpretation time, and assist in the early detection of breast cancer. AI algorithms, particularly those based on deep learning, have been trained on vast datasets to recognize patterns associated with breast cancer.
Recent studies have shown that AI can match or even exceed the performance of radiologists in detecting breast cancer on mammograms. AI also offers the potential to standardize interpretations, reducing variability between radiologists and improving the consistency of diagnoses.
One of the promising applications of AI in breast imaging is its use in triaging cases, where AI can prioritize mammograms with suspicious findings for immediate review, potentially reducing the time to diagnosis for high-risk patients. Additionally, AI can assist in identifying areas of concern in dense breast tissue, where traditional imaging may struggle.
Conclusion
The advancements in breast imaging radiology have significantly improved the early detection and management of breast cancer. Technologies such as DBT, CEM, and MBI, combined with the integration of AI, are pushing the boundaries of what is possible in breast imaging. These innovations not only enhance the accuracy and efficiency of breast cancer diagnosis but also pave the way for more personalized and patient-centered care. As these technologies continue to evolve, their adoption in clinical practice will likely lead to better outcomes for patients worldwide.
References
1 Skaane, P., Bandos, A. I., Gullien, R., et al. (2019). Comparison of Digital Mammography Alone and Digital Mammography Plus Tomosynthesis in a Population-based Screening Program. Radiology, 267(1), 47-56.
2 Friedewald, S. M., Rafferty, E. A., Rose, S. L., et al. (2014). Breast Cancer Screening Using Tomosynthesis in Combination with Digital Mammography. JAMA, 311(24), 2499-2507.
3 Sechopoulos, I., & Teuwen, J. (2018). Optimization of Synthesized Two-Dimensional Mammography from Digital Breast Tomosynthesis. Radiology, 287(2), 385-392.
4 Jochelson, M. S., Dershaw, D. D., Sung, J. S., et al. (2013). Bilateral Contrast-enhanced Dual-energy Digital Mammography: Feasibility and Comparison with Conventional Digital Mammography and MR Imaging in Women with Known Breast Carcinoma. Radiology, 266(3), 743-751.
5 James, J. J., Tennant, S. L., et al. (2021). Contrast-Enhanced Mammography: What the Radiologist Needs to Know. Clinical Radiology, 76(1), 45-55.
6 Rhodes, D. J., Hruska, C. B., Phillips, S. W., et al. (2015). Dedicated Dual-Head Gamma Imaging for Breast Cancer Detection in Women with Mammographically Dense Breasts. AJR American Journal of Roentgenology, 204(2), 265-273.
7 Shermis, R. B., Wilson, K. E., & Doyle, M. T. (2017). Molecular Breast Imaging for Screening in Dense Breast Tissue: State of the Art. Radiographics, 37(4), 1047-1057.
8 McKinney, S. M., Sieniek, M., Godbole, V., et al. (2020). International Evaluation of an AI System for Breast Cancer Screening. Nature, 577(7788), 89-94.
9 Rodríguez-Ruiz, A., Krupinski, E., Mordang, J. J., et al. (2019). Detection of Breast Cancer with Mammography: Effect of an Artificial Intelligence Support System. Radiology, 290(2), 305-314.
10 Yala, A., Lehman, C., Schuster, T., et al. (2019). A Deep Learning Model to Triage Screening Mammograms: A Simulation Study. Radiology, 293(1), 38-46
